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Int roduction
Carbamazepine has been proven to be efficacious in some pati ent s with affective
disorders, notably those who have not responded well to lithium ca rbonate or
neuro leptics (1,2,3) . For those who have responded poorly to either regimen, however,
there have been no effective pharmacotherapies until recently, when case reports have
suggested a possible synergistic action between lithium carbonat e and carbamazepine
(4,5,6). The following case report supports this hypothesis.
Case Report
A 43-year-old man diagnosed by DSM-III criteria as having a bipolar disorder,
manic type , was admitted to a psychiatric hospital, Coatesville VA Medical Center, for
the fourth time in two years . Admission physical and laboratory results, as well as a n
EEG, were unremarkable. During previous admissions, this pati ent had remained
unimproved despite adequate trials of a combination of lithium carbonate at plasma
levels of 1.0-1 .5 mliq / Iiter and high doses of various classes of neuroleptics. Aga in, on
this admission, the patient was unchanged despite high doses of neuroleptics, includ ing
chlorpromazine at up to 2000 mg.j'day, and lithium carbonate at levels of 0.9-1.5
rnliq / Iiter. On day eighteen carbamazepine was begun. Wihin four days the patient
displayed mar ked reduction of psychomotor agitation, aggressiveness, and irritab ility,
and on the twenty-second hospital day his chlorpromazine was discontinued. His
improvement continued with abatement of manic symptoms. On the fifty-seventh
hospital day, lithium carbonate was stopped to evalu ate the patient 's reponse to
carbamazepine alone. His carbamazepine level, which ranged from 4.6-6. 7 ugj ml
(therapeutic range for seizure disorde rs: 3-12 ug / rnl), was then 6.7 ug/ rnl. The pat ient
displayed a gra dual recrudescence of manic symptoms, including violent threats and
insomnia, as well as the new complaint of bru xism. Following reinstitution of lithium
carbonate on day seventy -seven, the patient's manic symptoms and his complai nts of
bruxism resolved within three days . He was discharged from the hospit al without
recurrence of his manic symptoms on the one-hundred-and-fifth hospital day. Four
months after discharge, he remains euthymic.
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This patient responded poorly to neuroleptics and lith ium carbonate, but
improved rapidly on a combination of carbam azepine and lithium carbonate. When an
attempt was made to discontinue the lithium carbonat e, the patient developed a
recurrence of his manic symptoms that resolved when it was reinstitu ted . Wh ile it
remains impossible to exclude a sponta neous remission, the temporal relationship
between treatment and symptom response appear s to support th e hypothesis that this
patient , while unresponsive to lithium carbonate and carbam azepine alone, responded
to a synergistic effect of the se drugs.
Elaboration of this proposed hypothesis awaits elucidati on of the methods of
action of the individual agents . Although a number of hypotheses exist (2, 7, 8) , their
incipient nature make speculation about the mechanism of ac tion of these agents'
apparent synergism premature.
While thi s and other case reports suggest the usefulness of a com bination of
lithi um carbonate and carbamazepine in otherwise tre atment-resistan t manic patients,
its role as a treatment modality in affective disorders, including its potential risks (6),
remain uncertainties that merit further study.
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